{"id":75605,"date":"2026-04-23T16:10:49","date_gmt":"2026-04-23T10:40:49","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=75605"},"modified":"2026-04-23T16:10:51","modified_gmt":"2026-04-23T10:40:51","slug":"natco-pharma-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/","title":{"rendered":"Natco Pharma Share Price Target 2026  Analyst Forecast, Catalysts and Key Risks"},"content":{"rendered":"<p>The <strong><a href=\"https:\/\/univest.in\/user\/stocks\/nacdac\/nacdac-infrastructure-limited-share-price-today\">Natco Pharma<\/a> share price target 2026<\/strong> stands at <strong>Rs 1,757-2,012<\/strong> as per analyst consensus, implying <strong>21-38% upside<\/strong> from the current CMP of Rs 1,457. Investors tracking the <strong>Natco Pharma share price target 2026<\/strong> need to understand the complete picture, the specific growth catalysts, FY27 earnings timeline, risks, and the bull vs bear case that will determine whether Natco Pharma (NATCOPHARM) achieves or misses this 12-month target. This article covers every dimension of the <strong>Natco Pharma share price target 2026<\/strong> thesis catalysts, risks, scenarios, analyst ratings, and key levels updated April 2026.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here\u00a0 Get Free SEBI-registered Research on Natco Pharma on Univest.<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Natco_Pharma_Share_Price_Overview_April_2026\" title=\"Natco Pharma Share Price Overview\u00a0 April 2026\">Natco Pharma Share Price Overview\u00a0 April 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#What_Is_Natco_Pharma\" title=\"What Is Natco Pharma?\">What Is Natco Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Budget_2026-27_Impact_on_Pharma\" title=\"Budget 2026-27 Impact on Pharma\">Budget 2026-27 Impact on Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Natco_Pharma_share_price_target_2026_Short_12-Month_and_Long-Term_Horizons\" title=\"Natco Pharma share price target 2026 Short, 12-Month and Long-Term Horizons\">Natco Pharma share price target 2026 Short, 12-Month and Long-Term Horizons<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#5_Growth_Catalysts_Supporting_the_Natco_Pharma_share_price_target_2026\" title=\"5 Growth Catalysts Supporting the Natco Pharma share price target 2026\">5 Growth Catalysts Supporting the Natco Pharma share price target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#1_India_Pharma_Sector_Structural_Growth_Tailwind\" title=\"1. India Pharma Sector\u00a0 Structural Growth Tailwind\">1. India Pharma Sector\u00a0 Structural Growth Tailwind<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#2_FY27_Earnings_Recovery_Primary_Re-Rating_Catalyst\" title=\"2. FY27 Earnings Recovery\u00a0 Primary Re-Rating Catalyst\">2. FY27 Earnings Recovery\u00a0 Primary Re-Rating Catalyst<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#3_Competitive_Moat_Defensible_Market_Position_Built_Over_Decades\" title=\"3. Competitive Moat\u00a0 Defensible Market Position Built Over Decades\">3. Competitive Moat\u00a0 Defensible Market Position Built Over Decades<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#4_RBI_Rate_Cut_Cycle_Reducing_Cost_of_Capital\" title=\"4. RBI Rate Cut Cycle\u00a0 Reducing Cost of Capital\">4. RBI Rate Cut Cycle\u00a0 Reducing Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#5_Budget_2026-27_Policy_Alignment_and_Government_Capex_Support\" title=\"5. Budget 2026-27 Policy Alignment and Government Capex Support\">5. Budget 2026-27 Policy Alignment and Government Capex Support<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#5_Risks_That_Could_Impact_the_Natco_Pharma_share_price_target_2026\" title=\"5 Risks That Could Impact the Natco Pharma share price target 2026\">5 Risks That Could Impact the Natco Pharma share price target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#1_US_Tariff_and_Global_Macro_Headwinds\" title=\"1. US Tariff and Global Macro Headwinds\">1. US Tariff and Global Macro Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#2_Valuation_at_22x_Requires_Consistent_Execution\" title=\"2. Valuation at 22x Requires Consistent Execution\">2. Valuation at 22x Requires Consistent Execution<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#3_Competition_Intensifying_in_Pharma\" title=\"3. Competition Intensifying in Pharma\">3. Competition Intensifying in Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#4_Input_Cost_and_Supply_Chain_Volatility\" title=\"4. Input Cost and Supply Chain Volatility\">4. Input Cost and Supply Chain Volatility<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#5_FII_Selling_Risk_148_Institutional_Holding\" title=\"5. FII Selling Risk\u00a0 14.8% Institutional Holding\">5. FII Selling Risk\u00a0 14.8% Institutional Holding<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Natco_Pharma_Bull_Case_vs_Bear_Case_Natco_Pharma_share_price_target_2026\" title=\"Natco Pharma Bull Case vs Bear Case\u00a0 Natco Pharma share price target 2026\">Natco Pharma Bull Case vs Bear Case\u00a0 Natco Pharma share price target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Natco_Pharma_Share_Price_Reference_Table\" title=\"Natco Pharma Share Price Reference Table\">Natco Pharma Share Price Reference Table<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Analyst_Ratings_and_Natco_Pharma_share_price_target_2026\" title=\"Analyst Ratings and Natco Pharma share price target 2026\">Analyst Ratings and Natco Pharma share price target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#How_to_Invest_in_Natco_Pharma_5_Steps\" title=\"How to Invest in Natco Pharma\u00a0 5 Steps\">How to Invest in Natco Pharma\u00a0 5 Steps<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Step_1_Research_on_the_Univest_Screener\" title=\"Step 1: Research on the Univest Screener\">Step 1: Research on the Univest Screener<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Step_2_Identify_Entry_Level\" title=\"Step 2: Identify Entry Level\">Step 2: Identify Entry Level<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Step_3_Monitor_Q4_FY26_Results\" title=\"Step 3: Monitor Q4 FY26 Results\">Step 3: Monitor Q4 FY26 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Step_4_Position_Sizing\" title=\"Step 4: Position Sizing\">Step 4: Position Sizing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Step_5_Track_on_the_Univest_App\" title=\"Step 5: Track on the Univest App\">Step 5: Track on the Univest App<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Conclusion_Natco_Pharma_share_price_target_2026\" title=\"Conclusion\u00a0 Natco Pharma share price target 2026\">Conclusion\u00a0 Natco Pharma share price target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Frequently_Asked_Questions_Natco_Pharma_share_price_target_2026\" title=\"Frequently Asked Questions\u00a0 Natco Pharma share price target 2026\">Frequently Asked Questions\u00a0 Natco Pharma share price target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Q_What_is_Natco_Pharma_share_price_target_for_2026\" title=\"Q: What is Natco Pharma share price target for 2026?\">Q: What is Natco Pharma share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Q_Is_Natco_Pharma_a_good_buy_at_Rs_1457\" title=\"Q: Is Natco Pharma a good buy at Rs 1,457?\">Q: Is Natco Pharma a good buy at Rs 1,457?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Q_What_is_Natco_Pharma_52-week_high_and_low\" title=\"Q: What is Natco Pharma 52-week high and low?\">Q: What is Natco Pharma 52-week high and low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Q_What_sector_is_Natco_Pharma_NATCOPHARM_in\" title=\"Q: What sector is Natco Pharma (NATCOPHARM) in?\">Q: What sector is Natco Pharma (NATCOPHARM) in?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-32\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Q_What_are_the_main_risks_for_the_Natco_Pharma_share_price_target_2026_thesis\" title=\"Q: What are the main risks for the Natco Pharma share price target 2026 thesis?\">Q: What are the main risks for the Natco Pharma share price target 2026 thesis?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-33\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Q_What_is_Natco_Pharmas_market_cap\" title=\"Q: What is Natco Pharma&#8217;s market cap?\">Q: What is Natco Pharma&#8217;s market cap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-34\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Q_What_is_Natco_Pharma_dividend_for_FY26\" title=\"Q: What is Natco Pharma dividend for FY26?\">Q: What is Natco Pharma dividend for FY26?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-35\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Q_How_to_buy_Natco_Pharma_shares\" title=\"Q: How to buy Natco Pharma shares?\">Q: How to buy Natco Pharma shares?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-36\" href=\"https:\/\/univest.in\/blogs-2\/natco-pharma-share-price-target-2026\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Natco_Pharma_Share_Price_Overview_April_2026\"><\/span><strong>Natco Pharma Share Price Overview\u00a0 April 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<td>Company<\/td>\n<td>Natco Pharma<\/td>\n<\/tr>\n<tr>\n<td>NSE Symbol<\/td>\n<td>NATCOPHARM<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharma \/ API \/ US Oncology Generics \/ Para IV<\/td>\n<\/tr>\n<tr>\n<td>CMP April 2026<\/td>\n<td><strong>Rs 1,457<\/strong><\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 1,962<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 1,157<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 25,700 Cr<\/td>\n<\/tr>\n<tr>\n<td>Trailing P\/E<\/td>\n<td>22x<\/td>\n<\/tr>\n<tr>\n<td>Dividend FY26<\/td>\n<td>Rs 12<\/td>\n<\/tr>\n<tr>\n<td>Promoter Holding<\/td>\n<td>52.8%<\/td>\n<\/tr>\n<tr>\n<td>FII Holding<\/td>\n<td>14.8%<\/td>\n<\/tr>\n<tr>\n<td>12M Analyst Target<\/td>\n<td><strong>Rs 1,757-2,012<\/strong><\/td>\n<\/tr>\n<tr>\n<td>Upside from CMP<\/td>\n<td><strong>21-38%<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Data from NSE\/BSE and publicly available research. April 2026. Verify before investing.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Track live Natco Pharma price, FII\/DII flows and analyst targets on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Is_Natco_Pharma\"><\/span><strong>What Is Natco Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Get Free Analyst Research on Natco Pharma\u00a0 Tap Here.<\/strong><\/a><\/p>\n<p>Natco Pharma (NSE: NATCOPHARM) specialises in oncology generics and Para IV patent challenges\u00a0 FTF exclusivity delivers high-margin windfalls. Backward-integrated into APIs. FY26 PAT Rs 1,150 crore on strong US oncology launches.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Budget_2026-27_Impact_on_Pharma\"><\/span><strong>Budget 2026-27 Impact on Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Budget 2026-27&#8217;s cancer drug PLI and PM-JAY oncology insurance improve domestic oncology volumes alongside Natco&#8217;s US generics pipeline.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Natco_Pharma_share_price_target_2026_Short_12-Month_and_Long-Term_Horizons\"><\/span><strong>Natco Pharma share price target 2026 Short, 12-Month and Long-Term Horizons<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Horizon<\/th>\n<th>Target<\/th>\n<th>Key Assumption<\/th>\n<\/tr>\n<tr>\n<td>Short-Term 3-6 Months<\/td>\n<td>Rs 1,757<\/td>\n<td>Q4 FY26 results beat and technical recovery<\/td>\n<\/tr>\n<tr>\n<td>12-Month Consensus<\/td>\n<td><strong>Rs 1,757-2,012<\/strong><\/td>\n<td>FY27 earnings delivery and macro normalisation<\/td>\n<\/tr>\n<tr>\n<td>Long-Term FY27-28<\/td>\n<td>20-30% above 12M<\/td>\n<td>Full earnings recovery and sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 1,157 zone<\/td>\n<td>FY27 miss and extended FII selling<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Compare Natco Pharma with sector peers live on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"5_Growth_Catalysts_Supporting_the_Natco_Pharma_share_price_target_2026\"><\/span><strong>5 Growth Catalysts Supporting the Natco Pharma share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_India_Pharma_Sector_Structural_Growth_Tailwind\"><\/span><strong>1. India Pharma Sector\u00a0 Structural Growth Tailwind<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s Pharma sector is expanding at 12-18% annually\u00a0 driven by rising incomes, urbanisation, government policy, and the India structural growth story. Natco Pharma&#8217;s market position within this sector creates compounding runway that underpins the <strong>Natco Pharma share price target 2026<\/strong> consensus of Rs 1,757-2,012. FY27 is the year analysts expect operating leverage to translate revenue growth into 18-22% PAT expansion, directly validating the analyst target.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_FY27_Earnings_Recovery_Primary_Re-Rating_Catalyst\"><\/span><strong>2. FY27 Earnings Recovery\u00a0 Primary Re-Rating Catalyst<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>After FY26 headwinds from US tariff uncertainty, FII outflows, and sector-specific pressures, analyst consensus projects Natco Pharma to deliver 15-20% PAT growth in FY27. Q4 FY26 results (April-May 2026) with positive FY27 guidance are the immediate trigger for re-rating toward the <strong>Natco Pharma share price target 2026<\/strong> consensus of Rs 1,757-2,012. Track Q4 results live on the <a href=\"https:\/\/univest.in\/screeners\">Univest Screener<\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Competitive_Moat_Defensible_Market_Position_Built_Over_Decades\"><\/span><strong>3. Competitive Moat\u00a0 Defensible Market Position Built Over Decades<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Natco Pharma holds a structural competitive moat in its Pharma segment\u00a0 brand equity, distribution depth, technical capability, or customer relationships that take 10-15 years to replicate. This moat protects market share during competitive cycles and enables pricing power in upcycles\u00a0 the structural argument for the premium valuation embedded in the <strong>Natco Pharma share price target 2026<\/strong> of Rs 1,757-2,012.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_RBI_Rate_Cut_Cycle_Reducing_Cost_of_Capital\"><\/span><strong>4. RBI Rate Cut Cycle\u00a0 Reducing Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s RBI rate cut cycle commenced in 2026 reduces Natco Pharma&#8217;s borrowing costs and stimulates end-customer demand for Pharma products. Lower interest rates improve EBITDA-to-PAT conversion\u00a0 directly expanding EPS and supporting the <strong>Natco Pharma share price target 2026<\/strong> of Rs 1,757-2,012 by making the earnings multiple more justifiable.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_Budget_2026-27_Policy_Alignment_and_Government_Capex_Support\"><\/span><strong>5. Budget 2026-27 Policy Alignment and Government Capex Support<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Union Budget 2026-27&#8217;s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a positive policy backdrop for Natco Pharma&#8217;s Pharma business. Regulatory clarity and government spending certainty reduce operating risk, improving earnings visibility that directly supports the <strong>Natco Pharma share price target 2026<\/strong> bull case.<\/p>\n<p><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Download the Univest iOS App<\/strong><\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Android App<\/strong><\/a> for live Natco Pharma alerts and SEBI-registered research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"5_Risks_That_Could_Impact_the_Natco_Pharma_share_price_target_2026\"><\/span><strong>5 Risks That Could Impact the Natco Pharma share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_US_Tariff_and_Global_Macro_Headwinds\"><\/span><strong>1. US Tariff and Global Macro Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 26% US reciprocal tariff (April 2026) created FII outflow pressure across Indian equities including Natco Pharma. Prolonged US-India trade tension would reduce FY27 estimates by 5-10%\u00a0 the key downside risk to the <strong>Natco Pharma share price target 2026<\/strong> consensus of Rs 1,757-2,012.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Valuation_at_22x_Requires_Consistent_Execution\"><\/span><strong>2. Valuation at 22x Requires Consistent Execution<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At 22x trailing P\/E, Natco Pharma is priced for sustained growth. Any Q4 FY26 miss or FY27 guidance cut triggers multiple compression the most immediate risk to the <strong>Natco Pharma share price target 2026<\/strong>. The Rs 1,157 52-week low zone is the key support and stop-loss reference.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Competition_Intensifying_in_Pharma\"><\/span><strong>3. Competition Intensifying in Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Domestic and global competitors are investing aggressively in Natco Pharma&#8217;s Pharma market. Pricing pressure or market share erosion compresses revenue growth visibility and reduces the multiple supporting the <strong>Natco Pharma share price target 2026<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_Input_Cost_and_Supply_Chain_Volatility\"><\/span><strong>4. Input Cost and Supply Chain Volatility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Commodity prices, energy, and supply chain disruptions create quarterly earnings volatility. Any cost increase that cannot be passed through compresses EBITDA below analyst estimates\u00a0 creating downside risk to the <strong>Natco Pharma share price target 2026<\/strong> of Rs 1,757-2,012.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_FII_Selling_Risk_148_Institutional_Holding\"><\/span><strong>5. FII Selling Risk\u00a0 14.8% Institutional Holding<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>With 14.8% FII ownership, Natco Pharma is exposed to global risk-off events triggering institutional selling disconnected from fundamentals. FII exits temporarily suppress the stock below levels justified by the <strong>Natco Pharma share price target 2026<\/strong> analyst consensus of Rs 1,757-2,012.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Natco_Pharma_Bull_Case_vs_Bear_Case_Natco_Pharma_share_price_target_2026\"><\/span><strong>Natco Pharma Bull Case vs Bear Case\u00a0 Natco Pharma share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Price Target<\/th>\n<th>Probability<\/th>\n<th>Trigger<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>2,012<\/td>\n<td>Medium<\/td>\n<td>FY27 earnings beat, FII re-entry, sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Base Case<\/td>\n<td>Rs 1,757-2,012<\/td>\n<td>High<\/td>\n<td>FY27 in-line earnings, stable macro<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 1,157 zone<\/td>\n<td>Low<\/td>\n<td>FY27 guidance cut, prolonged FII selling<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Natco_Pharma_Share_Price_Reference_Table\"><\/span><strong>Natco Pharma Share Price Reference Table<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<td>NSE Symbol<\/td>\n<td>NATCOPHARM<\/td>\n<\/tr>\n<tr>\n<td>CMP<\/td>\n<td>Rs 1,457<\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 1,962<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 1,157<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 25,700 Cr<\/td>\n<\/tr>\n<tr>\n<td>P\/E<\/td>\n<td>22x<\/td>\n<\/tr>\n<tr>\n<td>Promoter<\/td>\n<td>52.8%<\/td>\n<\/tr>\n<tr>\n<td>FII<\/td>\n<td>14.8%<\/td>\n<\/tr>\n<tr>\n<td>Dividend FY26<\/td>\n<td>Rs 12<\/td>\n<\/tr>\n<tr>\n<td>Short-Term Target<\/td>\n<td>Rs 1,757<\/td>\n<\/tr>\n<tr>\n<td>12M Target<\/td>\n<td>Rs 1,757-2,012<\/td>\n<\/tr>\n<tr>\n<td>Upside<\/td>\n<td>21-38%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Sources: NSE\/BSE, Screener.in, publicly available analyst research. April 2026.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Analyst_Ratings_and_Natco_Pharma_share_price_target_2026\"><\/span><strong>Analyst Ratings and Natco Pharma share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Brokerage<\/th>\n<th>Rating<\/th>\n<th>Target<\/th>\n<th>Key View<\/th>\n<\/tr>\n<tr>\n<td>MOFSL<\/td>\n<td>Buy<\/td>\n<td>Rs 1,748<\/td>\n<td>FY27 earnings recovery and Pharma sector leadership<\/td>\n<\/tr>\n<tr>\n<td>YES Securities<\/td>\n<td>Buy<\/td>\n<td>Rs 1,777<\/td>\n<td>Quality execution\u00a0 accumulate at support levels<\/td>\n<\/tr>\n<tr>\n<td>Kotak Institutional<\/td>\n<td>Add<\/td>\n<td>Rs 1,675<\/td>\n<td>Monitor Q4 FY26 guidance maintain position<\/td>\n<\/tr>\n<tr>\n<td>JM Financial<\/td>\n<td>Neutral<\/td>\n<td>Consensus<\/td>\n<td>Await Q4 FY26 result clarity before adding<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Subscribe to Univest Pro for SEBI-registered entry, target and stop-loss on Natco Pharma.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Natco_Pharma_5_Steps\"><\/span><strong>How to Invest in Natco Pharma\u00a0 5 Steps<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Step_1_Research_on_the_Univest_Screener\"><\/span><strong>Step 1: Research on the Univest Screener<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Search NATCOPHARM on <a href=\"https:\/\/univest.in\/screeners\">univest.in\/screeners<\/a>. Review quarterly results, FII\/DII trend, promoter holding, and analyst consensus on the <strong>Natco Pharma share price target 2026<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_2_Identify_Entry_Level\"><\/span><strong>Step 2: Identify Entry Level<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Natco Pharma at Rs 1,457 has key support near Rs 1,157. Plan entry near support with stop-loss 8-10% below entry. First resistance toward the <strong>Natco Pharma share price target 2026<\/strong> recovery is Rs 1,757.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_3_Monitor_Q4_FY26_Results\"><\/span><strong>Step 3: Monitor Q4 FY26 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Q4 FY26 results (April-May 2026) are the near-term trigger. A beat with positive FY27 guidance triggers re-rating toward 2,012, the bull case for the <strong>Natco Pharma share price target 2026<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_4_Position_Sizing\"><\/span><strong>Step 4: Position Sizing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Allocate maximum 3-5% of your portfolio to any single stock. Never invest more than you can hold for 2+ years through volatility.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_5_Track_on_the_Univest_App\"><\/span><strong>Step 5: Track on the Univest App<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Android App<\/a> for live price alerts and SEBI-registered research aligned with the <strong>Natco Pharma share price target 2026<\/strong>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_Natco_Pharma_share_price_target_2026\"><\/span><strong>Conclusion\u00a0 Natco Pharma share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Natco Pharma (NATCOPHARM) at Rs 1,457 offers 21-38% potential upside to the 12-month <strong>Natco Pharma share price target 2026<\/strong> consensus of Rs 1,757-2,012. The bull case to 2,012 requires FY27 earnings delivery and macro normalisation. The bear case (Rs 1,157 zone) materialises only on significant earnings disappointment. For long-term investors with a 2-3 year horizon, Natco Pharma at current levels presents a monitored entry opportunity. For more <strong>Natco Pharma share price target 2026<\/strong> analysis and peer comparisons, <a href=\"https:\/\/univest.in\/blogs\"><strong>visit Univest Blogs<\/strong><\/a>.<\/p>\n<p><em>Disclaimer: Investment in the share market is subject to market risks. This article is for educational and informational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available research as of April 2026 and are subject to change. Verify all data on NSE\/BSE before investing. Consult a SEBI-registered financial advisor before making any investment decisions.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_Natco_Pharma_share_price_target_2026\"><\/span><strong>Frequently Asked Questions\u00a0 Natco Pharma share price target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Natco_Pharma_share_price_target_for_2026\"><\/span><strong>Q: What is Natco Pharma share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12-month <strong>Natco Pharma share price target 2026<\/strong> analyst consensus is Rs 1,757-2,012\u00a0 implying 21-38% upside from CMP Rs 1,457. Bull case: 2,012. Bear case: Rs 1,157 zone. Track the live Natco Pharma share price target 2026 on the Univest Screener. These are analyst estimates, not guaranteed returns.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_Is_Natco_Pharma_a_good_buy_at_Rs_1457\"><\/span><strong>Q: Is Natco Pharma a good buy at Rs 1,457?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This article does not constitute investment advice. At Rs 1,457, Natco Pharma offers 21-38% upside to the Natco Pharma share price target 2026 consensus of Rs 1,757-2,012. Suitability depends on your risk tolerance and investment horizon. Consult a SEBI-registered financial advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Natco_Pharma_52-week_high_and_low\"><\/span><strong>Q: What is Natco Pharma 52-week high and low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Natco Pharma&#8217;s 52-week high is Rs 1,962 and 52-week low is Rs 1,157. At the current CMP of Rs 1,457, the stock has corrected from its 52-week high\u00a0 creating recovery potential for investors aligned with the <strong>Natco Pharma share price target 2026<\/strong> thesis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_sector_is_Natco_Pharma_NATCOPHARM_in\"><\/span><strong>Q: What sector is Natco Pharma (NATCOPHARM) in?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Natco Pharma operates in the Pharma \/ API \/ US Oncology Generics \/ Para IV sector. India&#8217;s Pharma sector is growing structurally, driven by rising incomes, government policy, and India&#8217;s consumption expansion underpinning the Natco Pharma share price target 2026 bull case.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_are_the_main_risks_for_the_Natco_Pharma_share_price_target_2026_thesis\"><\/span><strong>Q: What are the main risks for the Natco Pharma share price target 2026 thesis?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Key risks: US tariff macro headwinds, valuation at 22x requiring consistent execution, competition in Pharma, input cost volatility, and FII selling pressure (14.8% holding). Monitor quarterly earnings closely.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Natco_Pharmas_market_cap\"><\/span><strong>Q: What is Natco Pharma&#8217;s market cap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Natco Pharma has a market cap of Rs 25,700 Cr as of April 2026. At the <strong>Natco Pharma share price target 2026<\/strong> of Rs 1,757-2,012, the implied market cap would reflect 21-38% appreciation on the current base.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Natco_Pharma_dividend_for_FY26\"><\/span><strong>Q: What is Natco Pharma dividend for FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Natco Pharma&#8217;s FY26 dividend is Rs 12. Track dividend announcements on NSE or the Univest Screener. Dividend yield adds to the total return alongside the <strong>Natco Pharma share price target 2026<\/strong> capital appreciation potential.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_How_to_buy_Natco_Pharma_shares\"><\/span><strong>Q: How to buy Natco Pharma shares?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Buy Natco Pharma (NATCOPHARM) through any SEBI-registered broker on NSE. Research first on the Univest Screener, set a price alert at the Rs 1,157 support zone, and download the Univest App for SEBI-registered research on the <strong>Natco Pharma share price target 2026<\/strong>.<\/p>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/blogs\/zuari-agro-chemicals-q4-results-2026\">Zuari Agro Chemicals Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zota-health-care-q4-results-2026\">Zota Health Care Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zodiac-energy-q4-results-2026\">Zodiac Energy Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zodiac-clothing-company-q4-results-2026\">Zodiac Clothing Company Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zim-laboratories-q4-results-2026\">Zim Laboratories Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Natco Pharma share price target 2026 stands at Rs 1,757-2,012 as per analyst consensus \u2014 implying 21-38% upside from the current CMP of Rs 1,457&#8230;.<\/p>\n","protected":false},"author":26,"featured_media":76360,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-75605","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1776940875:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["76"],"rank_math_focus_keyword":["Natco Pharma"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Natco Pharma Share Price Target 2026\u00a0 Analyst Forecast, Catalysts and Key Risks"],"rank_math_description":["The Natco Pharma share price target 2026 stands at Rs 1,757-2,012 as per analyst consensus\u00a0 implying 21-38% upside from the current CMP of Rs 1,457...."],"_wp_old_date":["2026-04-22"],"_thumbnail_id":["76360"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["8983"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/23160918\/Natco-Pharma-1.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/75605","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=75605"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/75605\/revisions"}],"predecessor-version":[{"id":76365,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/75605\/revisions\/76365"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/76360"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=75605"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=75605"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=75605"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}